nCounter Analysis System

Digital Spatial Profiler

MALDI Biotyper® Sirius System

Microarray Scanner

MALDI Series System

Next Generation Sequencing

Genomic Profiling

Biomarker Discovery

Clinical Proteomics

Tissue Biomarker Discovery

Anti-Microbial Resistance Detection

Rapid Microbial Identification

Molecular Pathology

rapifleX® MALDI PharmaPulse®

rapifleX® MALDI Tissuetyper

Infectious Diseases

Genetic Disorders

Tissue Biomarker Discovery

Genomic Biomarker

Clinical Proteomics

CleanPlex SARS-CoV-2 Panel

CleanPlex SARS-CoV-2 Flex Panel

SARS-CoV-2 Emerging Variants Panel Add On

CleanPlex ACE2 and TMPRSS2 Panel

CleanPlex Respiratory Virus Research Panel

CleanPlex Custom NGS Panels

CleanPlex Hereditary Cancer Panel v2

CleanPlex OncoZoom Cancer Hotspot Panel

CleanPlex BRCA 1 & BRCA 2 Panel v3

CleanPlex TP53 Panel

AccuFusion RNA Lung Cancer Panel

OmniFusion RNA Lung Cancer Panel

CleanPlex UMI Lung Cancer Panel

CleanPlex TMB 500 Panel

CleanPlex Custom NGS Panels

CleanPlex CFTR Panel

CleanPlex Mitochondrial Disease Panel

CleanPlex Hereditary Cancer Panel v2

CleanPlex Custom NGS Panels

rapifleX® MALDI PharmaPulse®

MALDI-TOF MS

Talk to an Expert

Enquire Now

rapifleX® MALDI PharmaPulse®

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.

High-Throughput Screening

High-Throughput Screening

Half-maximal inhibitor concentration (IC50) is a key parameter in the drug discovery process. MALDI PharmaPulse® software supports assay development by featuring a dedicated method development module. Optimal assay conditions obtained using the method development module are applied during MALDI-TOF screening, for example aiming for IC50 determination, which is set up and executed in the software´s dedicated screening module.